Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors за авторством I. O. Zhaleiko, T. P. Perekhrestenko, D. I. Bilko, I. S. Dyagil, N. M. Bilko

Отримати повний текст

TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia за авторством N. I. Bilous, I. V. Abramenko, A. A. Chumak, I. S. Dyagil, Z. V. Martina

Отримати повний текст

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy за авторством I. O. Sviezhentseva, T. P. Perekhrestenko, D. I. Bilko, A. I. Gordienko, M. V. Diachenko, I. S. Dyagil

Отримати повний текст